Learn More
Enzo Life Sciences SP600125 (50mg). CAS: 129-56-6

Supplier: Enzo Life Sciences BMLEI3050050
Potent, cell permeable, selective, and reversible inhibitor of c-Jun N-terminal kinase (JNK) (IC50=40nM for JNK-1 and JNK-2 and 90nM for JNK-3). The inhibition is competitive with respect to ATP. Exhibits over 300-fold greater selectivity for JNK as compared to ERK1 and p38. Inhibits the phosphorylation of c-Jun and blocks the expression of IL-2, IFN-γ, TNF-α, and COX-2. Blocks IL-1-induced accumulation of phospho-Jun, induction of c-Jun transcription and anti CD3-induced apoptosis of CD4+ CD8+ thymocytes. Alternative name: Anthra(1,9-cd)pyrazol-6(2H)-one, 1,9-Pyrazoloanthrone. Purity: ≥98% (TLC). Solubility: Soluble in DMSO or methanol. Long Term Storage: Ambient.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.